Smart robot accelerates cancer treatment research
23 September 2015 | By Victoria White
The new smart research robot, developed at Uppsala University, accelerates research on cancer treatments by finding optimal treatment combinations...
List view / Grid view
23 September 2015 | By Victoria White
The new smart research robot, developed at Uppsala University, accelerates research on cancer treatments by finding optimal treatment combinations...
22 September 2015 | By Victoria White
The companies are validating the druggability of two kinase targets in a specific genetic context and have generated multiple novel chemical series against these targets...
17 September 2015 | By Victoria White
The researchers also determined that the level of biomarkers associated with ovarian cancer does not simply increase or decrease over the course of the disease...
17 September 2015 | By Victoria White
The research collaboration brings together Amgen's capabilities in target discovery and protein therapeutics with Xencor's XmAb bispecific technology platform...
14 September 2015 | By Victoria White
The five-year programme will focus on the development of ‘nanomedicine’ in the treatment of pancreatic cancer, for which current treatment options are limited...
14 September 2015 | By Victoria White
The new laboratory, opened in Cambridge, will focus on the discovery and development of novel biologic cancer treatments and diagnostics...
11 September 2015 | By Victoria White
Researchers have developed a new method for studying the targets and effects of cancer drugs using data from discovery mass spectrometry experiments...
10 September 2015 | By Victoria White
The SAS1B protein appears only on egg cells and cancer cells, and could serve as a target for tiny tracking probes created using monoclonal antibodies...
9 September 2015 | By Victoria White
New research suggests genetic inheritance is much more important in testicular cancer than in most other cancer types, where genetics typically accounts for less than 20% of risk...
4 September 2015 | By Victoria White
Research reveals exactly how the Polybia paulista wasp's venom toxin - called MP1 - selectively kills cancer cells without harming normal cells...
4 September 2015 | By Victoria White
Researchers have shown that combining immunotherapy with aspirin or other COX inhibitors substantially slowed bowel and melanoma skin cancer growth in mice...
4 September 2015 | By Victoria White
Researchers have identified a pathway that causes resistance to chemotherapy and radiation treatments and a new drug, KG5, that targets this pathway...
3 September 2015 | By Victoria White
Horizon and Redx have announced a new research collaboration to progress Redx’s pan-RAF inhibitor programme, for out-licensing in oncology indications...
2 September 2015 | By Victoria White
Nearly all advanced oesophageal cancers harbour genetic mutations that can be targeted with emerging drug therapies, according to a new study...
1 September 2015 | By Charlotte Batchelor
Bristol-Myers Squibb Company and QIMR Berghofer Medical Research Institute have signed a research collaboration and license agreement to discover novel therapeutic antibodies against an undisclosed immuno-oncology...